ALDX - Aldeyra Therapeutics, Inc.
1.57
-0.010 -0.637%
Share volume: 724,956
Last Updated: 04-28-2026
Pharmaceutical Products/Pharmaceutical Preparations:
-0.12%
PREVIOUS CLOSE
CHG
CHG%
$1.58
-0.01
-0.01%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-02-2024 | 08-01-2024 | 11-07-2024 | 02-28-2025 | 05-14-2025 | 08-07-2025 | 11-05-2025 | 02-27-2026 | |
| Cash flow financing | 18.191 K | 0.000 | -197.392 K | 7.779 K | 1.003 M | 0.000 | 120.746 K | 0.000 | |
| Other financing cash flows | 0.000 | 0.000 | 0.000 | 350.279 K | 983.194 K | 0.000 | 120.746 K | 0.000 | |
| Cash flow | -40.331 M | 0.000 | -2.910 M | -13.593 M | -4.176 M | 0.000 | 18.099 M | 0.000 | |
| Net income | -8.082 M | -16.848 M | -15.113 M | -15.809 M | -9.930 M | -9.767 M | -7.688 M | -6.462 M | |
| Depreciation | 60.632 K | 61.631 K | 62.987 K | 64.373 K | 60.912 K | 62.282 K | 63.683 K | 65.116 K | |
| Changes in inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Changes in receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Cashflow | -30.377 M | -18.238 M | 5.263 M | -1.564 M | 7.290 M | -554.126 K | 25.000 M | 16.000 M | |
| Net Borrowings | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cash Change | -40.331 M | -31.462 M | -2.910 M | -13.593 M | -4.176 M | -9.109 M | 18.099 M | 10.701 M |